New drug SR750 put to the test in healthy volunteers
NCT ID NCT06932536
First seen Jan 11, 2026 · Last updated May 15, 2026 · Updated 22 times
Summary
This early-stage study tested the safety and how the body processes a new drug called SR750 in 40 healthy Chinese adults aged 18 to 45. Participants received either the drug or a placebo, and researchers measured drug levels in the blood and monitored for side effects. The goal was to gather information, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Shanghai Clinical Research Center Phase I Clinical Research Unit (SCRC-PCRU)
Shanghai, Shanghai Municipality, China
Conditions
Explore the condition pages connected to this study.